
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
[ Thu, Apr 20th 2023 ]: WOPRAI
Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $53 on, Apr 20th, 2023


🞛 This publication is a summary or evaluation of another publication
Joseph Pantginis of HC Wainwright & Co., Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $53 on, Apr 20th, 2023.
Joseph has made no other calls on ATNM in the last 4 months.
There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, all agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andy Hsieh of "William Blair" Downgraded from Buy to Hold on, Tuesday, February 21st, 2023